MMP-9 plasma level as biomarker of cochlear implantation outcome in cohort study of deaf children.
Monika MatusiakDominika OziębłoMonika OłdakEmilia RejmakLeszek KaczmarekDominik DobekHenryk SkarżyńskiPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2023)
The study shows that children born deaf who have an MMP-9 plasma level of less than 150 ng/ml at cochlear implantation have a good chance of attaining a high LEAQ score after 18 months of speech and language rehabilitation. This indicates that MMP-9 plasma level at cochlear implantation is a good prognostic marker for CI outcome.